PI-103
CAS No. 371935-74-9
PI-103 ( PI 103 | PI103 )
产品货号. M14282 CAS No. 371935-74-9
一种有效的 I 类 PI3K/mTOR 双抑制剂,p110α/β/δ/γ 的 IC50 分别为 2/3/3/15/。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥781 | 有现货 |
|
| 10MG | ¥1216 | 有现货 |
|
| 25MG | ¥1841 | 有现货 |
|
| 50MG | ¥2678 | 有现货 |
|
| 100MG | ¥3141 | 有现货 |
|
| 200MG | ¥4473 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥818 | 有现货 |
|
生物学信息
-
产品名称PI-103
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述一种有效的 I 类 PI3K/mTOR 双抑制剂,p110α/β/δ/γ 的 IC50 分别为 2/3/3/15/。
-
产品描述A potent, dual class I PI3K/mTOR inhibitor with IC50 of 2/3/3/15/ for p110α/β/δ/γ, respectively; also inhibits TORC1 (>80% inhibition at 0.5 uM) and DNA-PK (IC50=14 nM), 15- to 20-fold less activity against class II PI3K C2β (IC50=43 nM), >1,300-fold selectivity over the class III PI3K Vsp34; potently inhibits proliferation and invasion of a wide variety of human cancer cells in vitro; shows activity in cancer xenograft models.
-
体外实验PI-103 exhibits antiproliferative properties in a panel of human cancer cell lines. PI-103 is essentially cytostatic for cell lines and induced cell cycle arrest in the G1 phase. In blast cells, PI-103 inhibits leukemic proliferation, the clonogenicity of leukemic progenitors and induces mitochondrial apoptosis, especially in the compartment containing leukemic stem cells . PI-103 potently inhibits both the rapamycin-sensitive (mTORC1, IC50=20 nM) and rapamycin-insensitive (mTORC2, IC50=83 nM) complexes of the protein kinase mTOR.
-
体内实验PI-103 shows therapeutic activity against a range of human tumor xenografts, exhibiting inhibition of angiogenesis, invasion, and metastasis, as well as direct antiproliferative effects. PI-103 induces immunosuppression promoting in vivo tumor growth and inhibiting apoptosis. Tumors from PI-103-treated mice shows higher levels of cyclin D1 and more proliferating cells.
-
同义词PI 103 | PI103
-
通路PI3K/Akt/mTOR signaling
-
靶点PI3K
-
受体DNA-PK|p110α|p110β|p110γ|p110δ|mTOR
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number371935-74-9
-
分子量348.3553
-
分子式C19H16N4O3
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESOC1=CC(=CC=C1)C1=NC2=C(OC3=C2C=CC=N3)C(=N1)N1CCOCC1 |c:3,5,13,16,18,21,t:1,8,10|
-
化学全称Phenol, 3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Fan QW, et al. Cancer Cell. 2006 May;9(5):341-9.
2. Raynaud FI, et al. Cancer Res. 2007 Jun 15;67(12):5840-50.
3. Fan QW, et al. Cancer Res. 2007 Sep 1;67(17):7960-5.
4. Kojima K, et al. Leukemia. 2008 Sep;22(9):1728-36.
产品手册
关联产品
-
mTOR inhibitor 9d
mTOR inhibitor 9d is a dual inhibitor of the protein kinases mTOR and PI3K with an mTOR IC50 value of 0.31 nm, and can be used for the treatment of leukemia, skin cancer, breast cancer, lung cancer and colon cancer.
-
RV-1729
RV-1729 是一种有效的选择性 PI3Kδ 抑制剂,IC50 为 12 nM。
-
IHMT-PI3Kδ-372 S-iso...
IHMT-PI3Kδ-372 S-isomer is a potent and selective PI3Kδ inhibitor with an IC50 of 14 nM. IHMT-PI3Kδ-372 S-isomer shows high selectivity over other class I PI3Ks (56~83 fold) and other protein kinases. IHMT-PI3Kδ-372 can be uesd for chronic obstructive pulmonary disease (COPD) research.
021-51111890
购物车()
sales@molnova.cn

